Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MRK
Recent news which mentions MRK
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Tickers
MRK
Tags
Health Canada Approval
Market News
MRK
From
Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
Tickers
MRK
OBSV
OGN
Tags
OBSV
General
Health Care
From
Benzinga
Got $1,000? 3 Stocks to Buy and Hold Until Retirement
September 13, 2022
Tickers
ARE
INVH
MRK
MRNA
Tags
Market News
MRK
O
From
Motley Fool
This Is What Whales Are Betting On Merck & Co
September 12, 2022
Tickers
MRK
Tags
Benzinga
Options
Market News
From
Benzinga
Analyst Ratings for Merck & Co
September 12, 2022
Tickers
MRK
Tags
Market News
Analyst Ratings
MRK
From
Benzinga
BP To $47? Plus UBS Sees $2,260 For This Stock
September 12, 2022
Tickers
ASO
AZO
BP
MRK
Tags
Price Target
AZO
News
From
Benzinga
Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer Patients
September 12, 2022
Tickers
MRK
Tags
Large Cap
Biotech
News
From
Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Tickers
ESALF
ESALY
MRK
Tags
Benzinga
Market News
MRK
From
Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Tickers
ADAP
ALLK
ARQT
AZN
Tags
MRK
Market News
PFE
From
Benzinga
Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week
September 09, 2022
Tickers
LLY
MRK
SHPH
Tags
SHPH
Market News
MRK
From
Motley Fool
AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer
September 09, 2022
Tickers
AZN
AZNCF
MRK
Tags
General
Briefs
News
From
Benzinga
Merck's Deal With Seagen May Have Fallen Through. Now What?
September 07, 2022
Tickers
MRK
SGEN
Tags
Market News
SGEN
MRK
From
Motley Fool
Why Ocugen Stock Topped the Market Today
September 01, 2022
Tickers
EBS
MRK
OCGN
Tags
Market News
MRK
Recent Press Releases
From
Motley Fool
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Tickers
AMD
AMZN
BA
BABA
Tags
Tech
MRK
FDA
From
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Tickers
GSK
MRK
NVS
Tags
General
Management
Briefs
From
Benzinga
Why Guardant Health Crushed the Market Today
August 31, 2022
Tickers
GH
MRK
Tags
GH
MRK
Market News
From
Motley Fool
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
Tickers
GSK
MRK
SNY
TAK
Tags
Biotech
GSK
SNY
From
Benzinga
Bristol Myers-JNJ Partnered Secondary Stroke Drug Misses Endpoint, But Companies See Enough Potential For Phase 3 Trials
August 29, 2022
Tickers
BMY
JNJ
MRK
Tags
Large Cap
Biotech
BMY
From
Benzinga
Benzinga Before The Bell: Elon Musk's Demand For Broad Twitter Data Dismissed, Xiaomi Wants To Join EV Race, Bed Bath & Beyond Plans To Share Turnaround Strategy Next Week And Other Top Financial Stor
August 26, 2022
Tickers
AMZN
BBBY
CMG
DASH
Tags
DASH
TSLA
FNCH
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 26, 2022
Tickers
AFRM
ATHX
AVCT
DNMR
Tags
Market News
KPRX
EVBG
From
InvestorPlace
Merck's Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report
August 26, 2022
Tickers
MRK
SGEN
Tags
Movers
why it's moving
News
From
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
Tickers
APTX
ATHE
AZN
DVAX
Tags
ATHE
IOVA
General
From
Benzinga
1 Bear Market Blunder Investors Are Still Making
August 25, 2022
Tickers
ABBV
MRK
MRNA
Tags
MRNA
Market News
MRK
From
Motley Fool
Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments
August 25, 2022
Tickers
AZN
AZNCF
MRK
Tags
Briefs
News
General
From
Benzinga
Do Warren Buffett's Recent Moves Spell Doom for This Group of Stocks?
August 25, 2022
Tickers
ABBV
BMY
BRK-A
BRK-B
Tags
MRK
JNJ
BRK/B
From
Motley Fool
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Tickers
AMGN
ARQT
BGNE
BMY
Tags
General
KALV
News
From
Benzinga
Merck Gets FDA Fast Track Status For Chronic Kidney Disease Candidate
August 23, 2022
Tickers
MRK
Tags
News
Biotech
General
From
Benzinga
Should Income Investors Buy This Dividend Stock?
August 23, 2022
Tickers
MRK
Tags
MRK
Market News
Recent Press Releases
From
Motley Fool
Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
August 22, 2022
Tickers
GILD
MRK
Tags
Health Care
European Medicines Agency
Biotech
From
Benzinga
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, Augus
August 22, 2022
Tickers
AAPL
AMZN
BBBY
BNTX
Tags
SGFY
MRK
TM
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.